T.Man Pharmaceutical Public Company Limited (TMAN.BK)
Thailand · THB · Healthcare · Drug Manufacturers - Specialty & Generic
THB 10.20 (-0.96%) as of
Key statistics
- Market cap
- 4.08B
- P/E (TTM)
- 8.03
- Forward P/E
- 7.34
- EPS (TTM)
- 1.27
- Dividend yield
- 5.44%
- 52-week range
- 9.95 – 13.60
- Beta
- 0.08
- Revenue (TTM)
- 2.62B
- Profit margin
- 19.34%
- Analyst target
- THB 17.40
- Volume
- 156.74k
About T.Man Pharmaceutical Public Company Limited
T.Man Pharmaceutical Public Company Limited manufactures and sells pharmaceuticals and health care products in Thailand. The company operates through three segments: Manufactured Products Under Own Brand, Manufactured Products Under Third Parties' Brand, and Trading Products. It offers antibacterial, central nervous system, corticosteroid, chronic diseases, gastrointestinal, respiratory, and musculoskeletal drugs, as well as medical devices, vaginal suppositories, dermatological, mouth, and throat products. The company also provides herbal and traditional medicines, dietary supplements, vitamins and minerals, skin care and aesthetics, whey protein, and mommy and kid products, as well as cosmetics, modern medicines, mossi guard, nevtral, propolis, and vita-c products. In addition, it offers products under various brand names, such as Iyara, Propoliz, POLAR, and Fibermate. The company also exports its products. Further, the company offers original equipment manufacturing services. Additionally, it offers medicines in the form of tablets, capsules, powders, liquids, and semisolids. The company also exports its products. T.Man Pharmaceutical Public Company Limited was founded in 1991 and is based in Bangkok, Thailand.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Bangkok, Thailand
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.